The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.
Q1 2022 c-suite not found.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 15, 2021 | Series Unknown | ¥100M | 4 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series Unknown |
|
— | Series Unknown |
![]() |
— | Series Unknown |
![]() |
— | Series Unknown |